title: Oral immune therapy: targeting the systemic immune system via the gut immune system for the treatment of inflammatory bowel disease.
abstract: Inflammatory bowel diseases (IBD) are associated with an altered systemic immune response leading to inflammation-mediated damage to the gut and other organs. Oral immune therapy is a method of systemic immune modulation via alteration of the gut immune system. It uses the inherit ability of the innate system of the gut to redirect the systemic innate and adaptive immune responses. Oral immune therapy is an attractive clinical approach to treat autoimmune and inflammatory disorders. It can induce immune modulation without immune suppression, has minimal toxicity and is easily administered. Targeting the systemic immune system via the gut immune system can serve as an attractive novel therapeutic method for IBD. This review summarizes the current data and discusses several examples of oral immune therapeutic methods for using the gut immune system to generate signals to reset systemic immunity as a treatment for IBD.
authors.affiliation: Gastroenterology and Liver Units, Department of Medicine, Hebrew University-Hadassah Medical Center , Jerusalem, Israel.
authors.forename: Yaron
authors.initials: Y
authors.lastname: Ilan